Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-31 @ 2:31 AM
Study NCT ID:
NCT07481058
Status:
RECRUITING
Last Update Posted:
2026-03-20
First Post:
2026-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer
Sponsor:
Beijing Konruns Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12
Completion Date Type:
ESTIMATED
First Submit Date:
2026-03-14
First Submit QC Date:
None
Study First Post Date:
2026-03-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-18
Last Update Post Date:
2026-03-20
Last Update Post Date Type:
ACTUAL